Joshua Makower, M.D. is a Consulting Associate Professor of Medicine at Stanford University Medical School and Co-Director of Stanford's Biomedical Technology Innovation Program. He is also the Founder, Chairman & Chief Technical Officer of TransVascular, Inc. a development stage, venture backed start-up company focused on the developing of a completely catheter-based coronary bypass technology. Dr. Makower also remains Founder and President of ExploraMed, Inc. the medical device incubator responsible for the creation of TransVascular, Inc. and EndoMatrix, Inc., a company focused on the development of a novel therapy for incontinence and GI Reflux, which was acquired by C.R. Bard in 1997.

Prior to that Dr. Makower was Founder and Manager of Pfizer's Strategic Innovation Group, a group chartered to create new medical device technologies and businesses for Pfizer's medical devices businesses. Dr. Makower was responsible for a string of new product development programs at Pfizer and holds over a dozen patents for various medical devices in the fields of Cardiology, General Surgery and Urology. Dr. Makower's role at Pfizer included management, business development, technology assessment and research and development.

Dr. Makower holds a Masters of Business Administration degree from Columbia University, a Doctor of Medicine degree from the New York University School of Medicine, and a Bachelor of Science degree in Mechanical Engineering from the Massachusetts Institute of Technology. Dr. Makower also serves on the Board of Directors for Iridex Medical, Inc. - a public company developing laser therapies for ophthalmologic diseases - and MedGenesis, Inc. - a venture backed private company developing innovative spinal therapies.